BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Celcuity Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-06-10 5:01 pm Purchase | 2024-05-30 | 13G | Celcuity Inc. CELC | BIOTECHNOLOGY VALUE FUND L P | 3,466,000 9.900% | 3,466,000 (New Position) | Filing |